View from the Thoraxcenter: TCT 22 Late-breaking Science Wrap-up

Watch on Radcliffe Cardiology: https://www.icrjournal.com/video-inde...

What are the top late-breaking science trials from #TCT2022?

View From the Thoraxcenter hosts, Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL) review the late-breaking science from the Transcatheter Cardiovascular Therapeutics (TCT) Conference 2022.
In this video you will learn more about the most impactful data and its application to practice and research.

Trials covered in detail include:
00:55:41: PROTECTED TAVR
04:47:13: CLASP II D
06:20:04: TVT Registry
09:42: The United Kingdom National Registry
11:44:32: Amulet IDE
13:18:45: SCOPE I
15:15:29: RADIANCE II Pivotal Trial
00:17:38: SYMPLICITY HTN-3
20:52:03: PADN-CFDA
22:45:42: UNIVERSAL
25:03:20: FLASH FlowTriever Mechanical Thrombectomy Registry
26:46:45: BEST
29:39:13: FAVOR III China
31:36:27: EPIC STEMI
33:02:21: COPS
34:58:04: EXIT-CALC

This content is intended for healthcare professionals only.

Radcliffe brings medical knowledge, insight and innovation to life for CV clinicians around the world, using our communications & creative expertise, our platforms and connections across the community to help transform theory into practice faster.